ClinicalTrials.Veeva

Menu

Immunohistochemical Expression Patterns of microRNA Processing Enzyme Dicer in Cutaneous Malignant Melanoma, Benign and Dysplastic Melanocytic Naevi

R

Ruhr University of Bochum

Status

Completed

Conditions

Malignant Melanoma
Naevi

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

MicroRNAs (miRNAs) are very small endogenous RNA molecules about 22-25 nucleotides in length, capable of post-transcriptional gene regulation. miRNAs bind to their target messenger RNAs (mRNAs), leading to cleavage or suppression of target mRNA translation based on the degree of complementarity. miRNAs have recently been shown to play pivotal roles in diverse developmental and cellular processes and linked to a variety of skin diseases and cancers. In the present study the researchers investigate the immunohistochemical distribution of Dicer in benign and dysplastic melanocytic naevi as well as in cutaneous malignant melanoma compared to intraindividual healthy control.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with benign melanocytic naevi, dysplastic melanocytic naevi and cutaneous malignant melanoma.

Exclusion criteria

  • Patients under 18 years of age
  • Patients with other forms of cancer in previous medical history
  • Pregnancy

Trial design

30 participants in 3 patient groups

1
Description:
benign melanocytic naevi
2
Description:
dysplastic melanocytic naevi
3
Description:
cutaneous malignant melanoma

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems